Duke-NUS Medical School researchers, together with collaborators in Singapore, have designed armoured immune cells that ...
To support COVID-19 vaccination efforts, the Singapore government is setting up four COVID-19 vaccination centres this m...
A team of scientists at the National University of Singapore (NUS) led by Dr Polly Leilei Chen from the C...
The FDA’s approvals of more cell and gene therapies (CGTs) are cause for celebration — but the marathon is n...
Holmusk has signed a Memorandum of Understanding (MOU) with Singapore's National Healthcare Group (NHG) and th...
Scientists at Nanyang Technological University, Singapore (NTU Singapore) have developed insulin nanoparticles that may ...
Ligature Therapeutics Pte Ltd, an early-stage biotech company developing small molecule ‘protein degrader’ t...
Singapore-based Heritas Capital Management is launching a $30 million fund, focusing around 10 to 15 early-stage pr...
The National University of Singapore (NUS) Graduate Research Innovation Programme (GRIP) has borne fruit in a ...
A team of researchers from the National University of Singapore (NUS) has created a novel film that is very effective in...
The Ministry of Health (MOH) at Singapore will introduce a vaccine injury financial assistance programme to provide supp...
Singapore kick-started its national Covid-19 vaccination programme on 30 Dec 2020, with a senior staff nurse w...
INEX Innovate, a Singapore-based molecular diagnostics developer, has announced that the Singapore Health Sciences ...
Concord Medical Services Holdings Limited, a healthcare provider specialising in cancer care, research and prevention by...
The Experimental Drug Development Centre (EDDC), a national platform for drug discovery and development hosted by A*STAR...
DHL, the leading global brand in the logistics industry has announced the successful delivery of the first batch of COVI...
Dental treatments are performed at close proximity to the mouths and noses of the patients, and the procedures are often...
Lumosa, based in Taiwan, has announced the market approval of LT1001 (Naldebain®), an extended-release analgesic i...
